CH642541A5 - Essentielle aminosaeuren enthaltende loesung zur verabreichung an krebspatienten. - Google Patents

Essentielle aminosaeuren enthaltende loesung zur verabreichung an krebspatienten. Download PDF

Info

Publication number: CH642541A5
Authority: CH; Switzerland
Prior art keywords: solution; amino acids; solutions; amino acid; patient
Prior art date: 1978-09-04

Application number

CH799179A

Other languages

German (de)

English (en)

Inventor

Koji Ozeki

Original Assignee

Otsuka Pharma Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1978-09-04

Filing date

1979-09-04

Publication date

1984-04-30

1979-09-04 Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd

1984-04-30 Publication of CH642541A5 publication Critical patent/CH642541A5/de

Links

150000001413 amino acids Chemical class 0.000 title claims description 48
206010028980 Neoplasm Diseases 0.000 title claims description 45
201000011510 cancer Diseases 0.000 title claims 6
239000000243 solution Substances 0.000 claims description 72
235000001014 amino acid Nutrition 0.000 claims description 47
229940024606 amino acid Drugs 0.000 claims description 47
101710204212 Neocarzinostatin Proteins 0.000 claims description 26
210000004881 tumor cell Anatomy 0.000 claims description 21
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 20
230000037396 body weight Effects 0.000 claims description 14
235000005911 diet Nutrition 0.000 claims description 14
230000037213 diet Effects 0.000 claims description 14
239000000203 mixture Substances 0.000 claims description 13
230000000694 effects Effects 0.000 claims description 12
239000004471 Glycine Substances 0.000 claims description 10
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 10
229930182817 methionine Natural products 0.000 claims description 10
COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims description 9
QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims description 9
AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims description 9
239000004473 Threonine Substances 0.000 claims description 9
QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims description 9
210000004027 cell Anatomy 0.000 claims description 9
238000001802 infusion Methods 0.000 claims description 9
COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims description 9
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 8
KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 8
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 8
KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 8
HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 8
239000004474 valine Substances 0.000 claims description 8
239000004475 Arginine Substances 0.000 claims description 7
AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 7
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 7
AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims description 7
229960000310 isoleucine Drugs 0.000 claims description 7
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 6
GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 claims description 6
WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 6
QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 6
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 6
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 6
PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 6
ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims description 6
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 6
235000004279 alanine Nutrition 0.000 claims description 6
239000002246 antineoplastic agent Substances 0.000 claims description 6
235000003704 aspartic acid Nutrition 0.000 claims description 6
OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims description 6
229940127089 cytotoxic agent Drugs 0.000 claims description 6
235000013922 glutamic acid Nutrition 0.000 claims description 6
239000004220 glutamic acid Substances 0.000 claims description 6
238000000034 method Methods 0.000 claims description 6
235000013930 proline Nutrition 0.000 claims description 6
235000004400 serine Nutrition 0.000 claims description 6
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 6
235000002374 tyrosine Nutrition 0.000 claims description 6
229940088594 vitamin Drugs 0.000 claims description 6
229930003231 vitamin Natural products 0.000 claims description 6
235000013343 vitamin Nutrition 0.000 claims description 6
239000011782 vitamin Substances 0.000 claims description 6
AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 5
235000015097 nutrients Nutrition 0.000 claims description 5
235000016709 nutrition Nutrition 0.000 claims description 5
LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 5
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 4
MJVAVZPDRWSRRC-UHFFFAOYSA-N Menadione Chemical compound C1=CC=C2C(=O)C(C)=CC(=O)C2=C1 MJVAVZPDRWSRRC-UHFFFAOYSA-N 0.000 claims description 4
230000002401 inhibitory effect Effects 0.000 claims description 4
150000003839 salts Chemical class 0.000 claims description 4
208000024891 symptom Diseases 0.000 claims description 4
AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 3
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 3
239000002253 acid Substances 0.000 claims description 3
229960002949 fluorouracil Drugs 0.000 claims description 3
235000013305 food Nutrition 0.000 claims description 3
239000008103 glucose Substances 0.000 claims description 3
206010073071 hepatocellular carcinoma Diseases 0.000 claims description 3
229960003512 nicotinic acid Drugs 0.000 claims description 3
235000001968 nicotinic acid Nutrition 0.000 claims description 3
239000011664 nicotinic acid Substances 0.000 claims description 3
229960002477 riboflavin Drugs 0.000 claims description 3
229940011671 vitamin b6 Drugs 0.000 claims description 3
150000003722 vitamin derivatives Chemical class 0.000 claims description 3
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims description 2
KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 2
229920002472 Starch Polymers 0.000 claims description 2
229930006000 Sucrose Natural products 0.000 claims description 2
JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 claims description 2
150000007513 acids Chemical class 0.000 claims description 2
235000010323 ascorbic acid Nutrition 0.000 claims description 2
229960005070 ascorbic acid Drugs 0.000 claims description 2
239000011668 ascorbic acid Substances 0.000 claims description 2
229960002685 biotin Drugs 0.000 claims description 2
235000020958 biotin Nutrition 0.000 claims description 2
239000011616 biotin Substances 0.000 claims description 2
239000003792 electrolyte Substances 0.000 claims description 2
230000012010 growth Effects 0.000 claims description 2
229960000367 inositol Drugs 0.000 claims description 2
CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims description 2
230000000968 intestinal effect Effects 0.000 claims description 2
QZGIWPZCWHMVQL-UIYAJPBUSA-N neocarzinostatin chromophore Chemical compound O1[C@H](C)[C@H](O)[C@H](O)[C@@H](NC)[C@H]1O[C@@H]1C/2=C/C#C[C@H]3O[C@@]3([C@@H]3OC(=O)OC3)C#CC\2=C[C@H]1OC(=O)C1=C(O)C=CC2=C(C)C=C(OC)C=C12 QZGIWPZCWHMVQL-UIYAJPBUSA-N 0.000 claims description 2
235000019192 riboflavin Nutrition 0.000 claims description 2
239000002151 riboflavin Substances 0.000 claims description 2
CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims description 2
239000008107 starch Substances 0.000 claims description 2
239000008223 sterile water Substances 0.000 claims description 2
239000005720 sucrose Substances 0.000 claims description 2
235000019157 thiamine Nutrition 0.000 claims description 2
229960003495 thiamine Drugs 0.000 claims description 2
239000011721 thiamine Substances 0.000 claims description 2
KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 claims description 2
235000012711 vitamin K3 Nutrition 0.000 claims description 2
239000011652 vitamin K3 Substances 0.000 claims description 2
229940041603 vitamin k 3 Drugs 0.000 claims description 2
229950009268 zinostatin Drugs 0.000 claims description 2
239000003797 essential amino acid Substances 0.000 claims 11
235000020776 essential amino acid Nutrition 0.000 claims 11
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims 6
239000004472 Lysine Substances 0.000 claims 6
AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 claims 5
ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims 5
AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 claims 5
UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 claims 5
229960003104 ornithine Drugs 0.000 claims 5
NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 claims 4
HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims 3
MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims 2
GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims 2
ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims 2
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims 2
NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims 2
239000000654 additive Substances 0.000 claims 2
229960004857 mitomycin Drugs 0.000 claims 2
OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims 1
VVIAGPKUTFNRDU-UHFFFAOYSA-N 6S-folinic acid Natural products C1NC=2NC(N)=NC(=O)C=2N(C=O)C1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 VVIAGPKUTFNRDU-UHFFFAOYSA-N 0.000 claims 1
102000009027 Albumins Human genes 0.000 claims 1
108010088751 Albumins Proteins 0.000 claims 1
GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims 1
FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims 1
FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims 1
MPJKWIXIYCLVCU-UHFFFAOYSA-N Folinic acid Natural products NC1=NC2=C(N(C=O)C(CNc3ccc(cc3)C(=O)NC(CCC(=O)O)CC(=O)O)CN2)C(=O)N1 MPJKWIXIYCLVCU-UHFFFAOYSA-N 0.000 claims 1
239000005715 Fructose Substances 0.000 claims 1
229930091371 Fructose Natural products 0.000 claims 1
RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims 1
241000287828 Gallus gallus Species 0.000 claims 1
206010061968 Gastric neoplasm Diseases 0.000 claims 1
AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims 1
GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims 1
206010061902 Pancreatic neoplasm Diseases 0.000 claims 1
DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 claims 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims 1
TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims 1
150000001242 acetic acid derivatives Chemical class 0.000 claims 1
239000004480 active ingredient Substances 0.000 claims 1
239000013543 active substance Substances 0.000 claims 1
229910000147 aluminium phosphate Inorganic materials 0.000 claims 1
230000002421 anti-septic effect Effects 0.000 claims 1
230000000259 anti-tumor effect Effects 0.000 claims 1
229940064004 antiseptic throat preparations Drugs 0.000 claims 1
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims 1
GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims 1
229940077731 carbohydrate nutrients Drugs 0.000 claims 1
150000001720 carbohydrates Chemical class 0.000 claims 1
235000014633 carbohydrates Nutrition 0.000 claims 1
210000001072 colon Anatomy 0.000 claims 1
201000010099 disease Diseases 0.000 claims 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
235000013601 eggs Nutrition 0.000 claims 1
210000003238 esophagus Anatomy 0.000 claims 1
239000003925 fat Substances 0.000 claims 1
235000019197 fats Nutrition 0.000 claims 1
235000008191 folinic acid Nutrition 0.000 claims 1
239000011672 folinic acid Substances 0.000 claims 1
VVIAGPKUTFNRDU-ABLWVSNPSA-N folinic acid Chemical compound C1NC=2NC(N)=NC(=O)C=2N(C=O)C1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 VVIAGPKUTFNRDU-ABLWVSNPSA-N 0.000 claims 1
229960002737 fructose Drugs 0.000 claims 1
230000002496 gastric effect Effects 0.000 claims 1
229960001031 glucose Drugs 0.000 claims 1
235000020256 human milk Nutrition 0.000 claims 1
210000004251 human milk Anatomy 0.000 claims 1
150000003840 hydrochlorides Chemical class 0.000 claims 1
238000002347 injection Methods 0.000 claims 1
239000007924 injection Substances 0.000 claims 1
238000010253 intravenous injection Methods 0.000 claims 1
229960001691 leucovorin Drugs 0.000 claims 1
238000012423 maintenance Methods 0.000 claims 1
229960002160 maltose Drugs 0.000 claims 1
HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims 1
CMUOJBJRZUHRMU-UHFFFAOYSA-N nitrourea Chemical compound NC(=O)N[N+]([O-])=O CMUOJBJRZUHRMU-UHFFFAOYSA-N 0.000 claims 1
230000035764 nutrition Effects 0.000 claims 1
201000002528 pancreatic cancer Diseases 0.000 claims 1
229940055726 pantothenic acid Drugs 0.000 claims 1
235000019161 pantothenic acid Nutrition 0.000 claims 1
239000011713 pantothenic acid Substances 0.000 claims 1
235000016236 parenteral nutrition Nutrition 0.000 claims 1
230000002980 postoperative effect Effects 0.000 claims 1
238000002360 preparation method Methods 0.000 claims 1
235000008160 pyridoxine Nutrition 0.000 claims 1
239000011677 pyridoxine Substances 0.000 claims 1
210000000664 rectum Anatomy 0.000 claims 1
230000001603 reducing effect Effects 0.000 claims 1
210000002966 serum Anatomy 0.000 claims 1
235000010267 sodium hydrogen sulphite Nutrition 0.000 claims 1
239000002904 solvent Substances 0.000 claims 1
239000000600 sorbitol Substances 0.000 claims 1
229960002920 sorbitol Drugs 0.000 claims 1
235000010356 sorbitol Nutrition 0.000 claims 1
239000003381 stabilizer Substances 0.000 claims 1
235000019698 starch Nutrition 0.000 claims 1
229940032147 starch Drugs 0.000 claims 1
210000002784 stomach Anatomy 0.000 claims 1
229960004793 sucrose Drugs 0.000 claims 1
230000004614 tumor growth Effects 0.000 claims 1
239000013585 weight reducing agent Substances 0.000 claims 1
239000000811 xylitol Substances 0.000 claims 1
229960002675 xylitol Drugs 0.000 claims 1
235000010447 xylitol Nutrition 0.000 claims 1
HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims 1
241001465754 Metazoa Species 0.000 description 23
241000700159 Rattus Species 0.000 description 8
239000003978 infusion fluid Substances 0.000 description 8
230000000875 corresponding effect Effects 0.000 description 7
230000004083 survival effect Effects 0.000 description 7
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 6
238000011081 inoculation Methods 0.000 description 6
235000021476 total parenteral nutrition Nutrition 0.000 description 5
PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 4
241000700157 Rattus norvegicus Species 0.000 description 3
238000002513 implantation Methods 0.000 description 3
238000011835 investigation Methods 0.000 description 3
229910052757 nitrogen Inorganic materials 0.000 description 3
NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 2
VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
206010039491 Sarcoma Diseases 0.000 description 2
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
235000019169 all-trans-retinol Nutrition 0.000 description 2
239000011717 all-trans-retinol Substances 0.000 description 2
229960003589 arginine hydrochloride Drugs 0.000 description 2
OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
238000013110 gastrectomy Methods 0.000 description 2
JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
229960003646 lysine Drugs 0.000 description 2
-1 sucrose vitamin Chemical class 0.000 description 2
238000012360 testing method Methods 0.000 description 2
238000002054 transplantation Methods 0.000 description 2
235000019155 vitamin A Nutrition 0.000 description 2
239000011719 vitamin A Substances 0.000 description 2
229940045997 vitamin a Drugs 0.000 description 2
NMNYMRMXUPRAKF-TYHJCQIPSA-N (2s,3s)-2-amino-3-methylpentanoic acid;(2s)-2,6-diaminohexanoic acid Chemical compound CC[C@H](C)[C@H](N)C(O)=O.NCCCC[C@H](N)C(O)=O NMNYMRMXUPRAKF-TYHJCQIPSA-N 0.000 description 1
239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 description 1
KXEASOROAFAOHX-ZAHKZPOQSA-N 4-methoxy-6-[(e)-2-[4-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]ethenyl]pyran-2-one Chemical compound O1C(=O)C=C(OC)C=C1\C=C\C(C=C1)=CC=C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 KXEASOROAFAOHX-ZAHKZPOQSA-N 0.000 description 1
206010003445 Ascites Diseases 0.000 description 1
235000019743 Choline chloride Nutrition 0.000 description 1
ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
206010022653 Intestinal haemorrhages Diseases 0.000 description 1
206010023126 Jaundice Diseases 0.000 description 1
206010027476 Metastases Diseases 0.000 description 1
OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
206010030113 Oedema Diseases 0.000 description 1
235000021314 Palmitic acid Nutrition 0.000 description 1
229930003270 Vitamin B Natural products 0.000 description 1
229930003471 Vitamin B2 Natural products 0.000 description 1
229930003268 Vitamin C Natural products 0.000 description 1
206010047700 Vomiting Diseases 0.000 description 1
206010052428 Wound Diseases 0.000 description 1
208000027418 Wounds and injury Diseases 0.000 description 1
208000009916 Yoshida Sarcoma Diseases 0.000 description 1
238000012084 abdominal surgery Methods 0.000 description 1
210000003815 abdominal wall Anatomy 0.000 description 1
229960003121 arginine Drugs 0.000 description 1
238000001574 biopsy Methods 0.000 description 1
FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
229960002079 calcium pantothenate Drugs 0.000 description 1
239000001913 cellulose Substances 0.000 description 1
229920002678 cellulose Polymers 0.000 description 1
235000013339 cereals Nutrition 0.000 description 1
238000006243 chemical reaction Methods 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
229960003178 choline chloride Drugs 0.000 description 1
SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 description 1
229910000366 copper(II) sulfate Inorganic materials 0.000 description 1
230000006378 damage Effects 0.000 description 1
238000001514 detection method Methods 0.000 description 1
229960000304 folic acid Drugs 0.000 description 1
235000019152 folic acid Nutrition 0.000 description 1
239000011724 folic acid Substances 0.000 description 1
210000004013 groin Anatomy 0.000 description 1
230000002440 hepatic effect Effects 0.000 description 1
235000014655 lactic acid Nutrition 0.000 description 1
239000004310 lactic acid Substances 0.000 description 1
DJQJFMSHHYAZJD-UHFFFAOYSA-N lidofenin Chemical compound CC1=CC=CC(C)=C1NC(=O)CN(CC(O)=O)CC(O)=O DJQJFMSHHYAZJD-UHFFFAOYSA-N 0.000 description 1
229910052943 magnesium sulfate Inorganic materials 0.000 description 1
238000005259 measurement Methods 0.000 description 1
230000009401 metastasis Effects 0.000 description 1
229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
IPCSVZSSVZVIGE-UHFFFAOYSA-N n-hexadecanoic acid Natural products CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
LHZDKNLVYWYRSS-UHFFFAOYSA-N panamin Natural products C1CCC(NC1)C23CC(CC4CCCN=C24)C5CCCCN5C3 LHZDKNLVYWYRSS-UHFFFAOYSA-N 0.000 description 1
229940101267 panthenol Drugs 0.000 description 1
235000020957 pantothenol Nutrition 0.000 description 1
239000011619 pantothenol Substances 0.000 description 1
206010034674 peritonitis Diseases 0.000 description 1
235000021395 porridge Nutrition 0.000 description 1
RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
239000011764 pyridoxine hydrochloride Substances 0.000 description 1
229940108325 retinyl palmitate Drugs 0.000 description 1
235000019172 retinyl palmitate Nutrition 0.000 description 1
239000011769 retinyl palmitate Substances 0.000 description 1
239000011833 salt mixture Substances 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
239000000126 substance Substances 0.000 description 1
235000019156 vitamin B Nutrition 0.000 description 1
239000011720 vitamin B Substances 0.000 description 1
235000019164 vitamin B2 Nutrition 0.000 description 1
239000011716 vitamin B2 Substances 0.000 description 1
235000019158 vitamin B6 Nutrition 0.000 description 1
239000011726 vitamin B6 Substances 0.000 description 1
235000019154 vitamin C Nutrition 0.000 description 1
239000011718 vitamin C Substances 0.000 description 1
230000008673 vomiting Effects 0.000 description 1
239000011592 zinc chloride Substances 0.000 description 1
235000005074 zinc chloride Nutrition 0.000 description 1
JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

CH799179A 1978-09-04 1979-09-04 Essentielle aminosaeuren enthaltende loesung zur verabreichung an krebspatienten. CH642541A5 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP10874978A JPS5535049A (en)	1978-09-04	1978-09-04	Amino acid transfusion for cancerous patient

Publications (1)

Publication Number	Publication Date
CH642541A5 true CH642541A5 (de)	1984-04-30

Family

ID=14492527

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CH799179A CH642541A5 (de)	1978-09-04	1979-09-04	Essentielle aminosaeuren enthaltende loesung zur verabreichung an krebspatienten.

Country Status (10)

Country	Link
JP (1)	JPS5535049A (fr)
AU (1)	AU526207B2 (fr)
CA (1)	CA1134275A (fr)
CH (1)	CH642541A5 (fr)
DE (1)	DE2935709C2 (fr)
FR (1)	FR2434622A1 (fr)
GB (1)	GB2029220B (fr)
IT (1)	IT1194844B (fr)
NL (1)	NL190266C (fr)
SE (1)	SE448679B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1995013061A1 (fr) *	1993-11-09	1995-05-18	Immunal Kft.	Compositions pharmaceutiques destinees a la prevention et au traitement de maladies cancereuses ainsi que leur procede de preparation

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS58500526A (ja) *	1981-04-17	1983-04-07	アメリカン　ホスピタル　サプライ　コ−ポレ−シヨン	非経口栄養供給のための改良溶液
FR2508797B1 (fr) *	1981-07-03	1986-03-14	Charles Chany	Medicament comprenant le produit de la reaction d'un acide carboxylique en c1 a c6 sur un amino-acide basique
DE3329253A1 (de) *	1983-08-12	1985-02-21	Milupa Ag, 6382 Friedrichsdorf	Verwendung eines aminosaeuregemisches zur bekaempfung insbesondere von lymphadenomen
HU191598B (en) *	1984-03-20	1987-03-30	Egyt Gyogyszervegyeszeti Gyar	Method for the preparation of injection solution suitable preferably against cathosis
DE3440090A1 (de) *	1984-11-02	1986-05-07	Novo-Med AG, Appenzell	Aminosaeureloesungen enthaltendes arzneimittel zur therapie von krebserkrankungen und verfahren zu seiner herstellung
IL77629A (en) *	1985-01-22	1989-07-31	Abbott Lab	High fat,low carbohydrate enteral nutritional for mula
FR2591893B1 (fr) *	1985-12-19	1988-11-10	Centre Nat Rech Scient	Compositions nutritionnelles carencees en methionine destinees a inhiber le developpement et la dissemination des tumeurs malignes chez les mammiferes
US5162373A (en) *	1986-01-17	1992-11-10	Board Of Regents, The University Of Texas System	Methods and improved formulations for the determination and treatment of malignant disease in patients
US5189025A (en) *	1988-12-09	1993-02-23	Board Of Regenets, The University Of Texas System	Methods for the treatment of malignant disease in patients using citrulline containing amino acid solutions
GB8917660D0 (en) *	1989-08-02	1989-09-20	Rana Ashok S J	Prophylaxis of transurethral resection reactions
WO1993006834A1 (fr) *	1991-10-07	1993-04-15	Otsuka Pharmaceutical Factory, Inc.	Preparation enterique destinee au traitement du cancer
US5658895A (en) *	1991-10-07	1997-08-19	Otsuka Pharmaceutical Factory, Inc.	Anticancer enteral feeding composition
DE4228897A1 (de) *	1992-08-29	1994-03-03	Wella Ag	Mittel zur Festigung der Haare auf der Basis von Lignin oder Ligninderivaten sowie Dihydroxypropyllignin
JP2930723B2 (ja) *	1992-11-19	1999-08-03	アンティキャンサーインコーポレーテド	抗メチオニン化学療法における抗腫瘍薬としてのメチオニナーゼの使用
RU2125874C1 (ru) *	1994-07-04	1999-02-10	Казанский государственный университет им.В.И.Ульянова-Ленина	Композиция аминокислот с микроэлементами, обладающая противоопухолевой и антигипоксической активностью
JP2000515874A (ja) *	1996-07-30	2000-11-28	ノバルテイス・ニユートリシヨン・アクチエンゲゼルシヤフト	アミノ酸組成物、ならびに腫瘍の成長および転移の処置におけるその使用
EP1068868A3 (fr) *	1997-07-08	2001-01-31	Rath, Matthias, Dr. med.	Compositions synergiques comportant l'ascorbate et la lysine pour des états associés à la dégénération de la matrice extracellulaire
RU2144821C1 (ru) *	1999-02-16	2000-01-27	Товарищество с ограниченной ответственностью Фирма "ГЛЕС"	Противоопухолевое средство
ATE323479T1 (de) *	2000-06-16	2006-05-15	Matthias Dr Med Rath	Zusammensetzung für die verhinderung der glattmuskelkrankheiten, die ascorbat, arginin und magnesium enthält
ATE327747T1 (de) *	2000-10-09	2006-06-15	Matthias Dr Med Rath	Therapeutische kombination des ascorbats mit lysin und arginin für verhinderung und behandlung des krebses
CH694549A5 (de)	2001-01-16	2005-03-31	Dr Matthias Rath	Verwendung einer synergistischen Zusammensetzung, die Ascorbat und Lysin für Zustände enthält zur Behandlung extrazellularer Matrixdegeration.
US6686340B2 (en)	2001-06-19	2004-02-03	Matthias Rath	Composition and method for prevention and treatment of health conditions caused by constriction of smooth muscle cells
SG106614A1 (en) *	2001-06-21	2004-10-29	Matthias Rath Dr	Use of biochemical substances for a composition for the prevention and treatment of health conditions caused by constriction of smooth muscle cells in organs of the human body
JPWO2003030890A1 (ja) *	2001-10-05	2005-02-10	哲朗浅尾	免疫系活性化剤
US20030105104A1 (en) *	2001-11-27	2003-06-05	Burzynski Stanislaw R.	Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy
US20050053664A1 (en)	2003-09-08	2005-03-10	Eliezer Zomer	Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer
JP2007529554A (ja) *	2004-03-19	2007-10-25	プロ−ファーマシューティカルズ，インク．	多価リガンド結合糖質ポリマーを用いた組成物、および該組成物による転移腫瘍の標的療法
WO2007016953A1 (fr) *	2005-07-29	2007-02-15	Matuschka-Greiffenclau Markus	Composition réduisant les risques de cancer du foie induit par l’alcool
WO2007016952A1 (fr) *	2005-07-29	2007-02-15	Matuschka-Greiffenclau Markus	Composition réduisant les risques de cancer de l’oesophage ou de l’oropharyngolaryngée induit par l’alcool
WO2007016954A1 (fr) *	2005-07-29	2007-02-15	Matuschka-Greiffenclau Markus	Composition réduisant les risques de cancer du sein induit par l’alcool ou les médicaments
WO2007016949A1 (fr) *	2005-07-29	2007-02-15	Matuschka-Greiffenclau Markus	Composition réduisant les risques de neuropathie induite par l’alcool
WO2007016951A1 (fr) *	2005-07-29	2007-02-15	Matuschka-Greiffenclau Markus	Composition réduisant les risques de cancer du pancréas induit par l’alcool
WO2007016950A1 (fr) *	2005-07-29	2007-02-15	Matuschka-Greiffenclau Markus	Composition réduisant les risques de maladie neurodégénérative induite par l’alcool
ATE554663T1 (de) *	2005-07-29	2012-05-15	Tima Foundation	Zusammensetzung zur steuerung des alkohol metabolismus und zur reduktion des risikos von alkoholbedingten krankheiten
US8865646B2 (en)	2007-03-28	2014-10-21	University Of South California	Dietary compositions and methods for protection against chemotherapy, radiotherapy, oxidative stress, and aging
EP2156188B1 (fr)	2007-03-28	2021-05-05	University of Southern California	Induction d'une résistance différentielle au stress et utilisations de celle-ci
JP2011523626A (ja) *	2008-04-24	2011-08-18	ユニバーシティーオブサウザンカリフォルニア，ユーエスシースティーブンズ	化学療法、放射線療法、酸化ストレス、および加齢を防御するための食事組成物ならびに方法
WO2012111790A1 (fr) *	2011-02-17	2012-08-23	味の素株式会社	Potentialisateur de l'activité antitumorale d'un agent chimiothérapique
JP2016117702A (ja) *	2014-12-22	2016-06-30	武輝山田	ガン細胞の死滅法
JOP20190146A1 (ar)	2016-12-19	2019-06-18	Axcella Health Inc	تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
WO2019036471A1 (fr)	2017-08-14	2019-02-21	Axcella Health Inc.	Acides aminés à chaîne ramifiée pour le traitement d'une maladie du foie
EP3810123A1 (fr)	2018-06-20	2021-04-28	Axcella Health Inc.	Compositions et procédés pour le traitement de l'infiltration de graisse dans le muscle
IT201900002109A1 (it)	2019-02-13	2020-08-13	Professional Dietetics Spa	Composizioni comprendenti amminoacidi per l'uso nel trattamento di lesioni del sistema nervoso centrale
IT202000000454A1 (it) *	2020-01-13	2021-07-13	Professional Dietetics Spa	Composizioni comprendenti amino acidi per la prevenzione e il trattamento del cancro
IT202000000442A1 (it)	2020-01-13	2021-07-13	Professional Dietetics Spa	Composizioni comprendenti amino acidi per l'uso nella prevenzione e nel trattamento di effetti collaterali della chemioterapia

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AT297935B (de) *	1968-05-09	1972-04-10	Astra Ab	Verfahren zur Herstellung einer Infusionslösung von essentiellen Aminosäuren zur intravenösen Zufuhr bei urämischen Zuständen
SU423304A3 (fr) *	1970-03-10	1974-04-05	Тейзо Хигаси, Дзинносуке Лбе, Теруо Таке, Сусуми Ватанабе , Масару Отани
DE2013026C3 (de) *	1970-03-19	1981-01-29	Wagner, Karl-Heinz, Prof. Dr.Med.Habil., 6300 Giessen	Mittel zur Behandlung und Verhütung von Leberkrankheiten und muskulärer Insuffizienz
DE2530246A1 (de) *	1975-07-07	1977-01-13	Fresenius Chem Pharm Ind	L-aminosaeuregemische fuer parenterale oder orale anwendung
DE2531204C2 (de) *	1975-07-12	1987-01-22	Fresenius AG, 6380 Bad Homburg	L-Aminosäuregemische für die parenterale oder orale Ernährung

1978
- 1978-09-04 JP JP10874978A patent/JPS5535049A/ja active Granted
1979
- 1979-08-28 GB GB7929789A patent/GB2029220B/en not_active Expired
- 1979-08-29 AU AU50368/79A patent/AU526207B2/en not_active Expired
- 1979-08-31 CA CA334,841A patent/CA1134275A/fr not_active Expired
- 1979-09-03 FR FR7921975A patent/FR2434622A1/fr active Granted
- 1979-09-03 SE SE7907316A patent/SE448679B/sv not_active IP Right Cessation
- 1979-09-03 IT IT05216/79A patent/IT1194844B/it active
- 1979-09-04 NL NLAANVRAGE7906620,A patent/NL190266C/xx not_active IP Right Cessation
- 1979-09-04 DE DE2935709A patent/DE2935709C2/de not_active Expired
- 1979-09-04 CH CH799179A patent/CH642541A5/de not_active IP Right Cessation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1995013061A1 (fr) *	1993-11-09	1995-05-18	Immunal Kft.	Compositions pharmaceutiques destinees a la prevention et au traitement de maladies cancereuses ainsi que leur procede de preparation

Also Published As

Publication number	Publication date
GB2029220B (en)	1983-03-30
JPS6154007B2 (fr)	1986-11-20
JPS5535049A (en)	1980-03-11
DE2935709A1 (de)	1980-03-13
NL190266B (nl)	1993-08-02
SE7907316L (sv)	1980-03-05
NL7906620A (nl)	1980-03-06
NL190266C (nl)	1994-01-03
AU5036879A (en)	1980-03-13
DE2935709C2 (de)	1986-02-06
FR2434622B1 (fr)	1983-04-15
GB2029220A (en)	1980-03-19
IT7905216A0 (it)	1979-09-03
SE448679B (sv)	1987-03-16
CA1134275A (fr)	1982-10-26
FR2434622A1 (fr)	1980-03-28
IT1194844B (it)	1988-09-28
AU526207B2 (en)	1982-12-23

Legal Events

Date	Code	Title	Description
1999-09-30	PL	Patent ceased

Publication	Publication Date	Title
DE2935709C2 (de)	1986-02-06	Aminosäurelösung zur Behandlung von an Krebs erkrankten Personen
DE3302008C2 (fr)	1992-08-20
DE60118172T2 (de)	2007-03-08	Verabreichung von einer chemoschützenden verbindung,welche eine thiolgruppe enthält
DE2556100C2 (fr)	1987-06-19
DE69927125T2 (de)	2006-05-18	Zusammensetzung gegen Erhöhung oder zur Herabsetzung des Blutzuckerspiegels
EP1337236B1 (fr)	2004-08-04	Complement a administrer par voie enterale pour nutrition parenterale ou nutrition enterale/orale partielle dans le cas de maladies critiques ou chroniques et de malnutrition
DE69928410T2 (de)	2006-08-03	Selenium enthaltende zusammensetzung zur behandlung von systemischen entzündungssyndromen
DE69914084T2 (de)	2004-10-28	Phenylacetylglutamin, phenylacetylisoglutamin, und/oder phenylacetat zur behandlung von neoplastischen erkrankungen
DE3875322T2 (de)	1993-05-13	Aminosaeure-zusammensetzung als traeger fuer die parenterale ernaehrung.
DE602004004817T2 (de)	2007-11-22	Myo-inositol hexaphosphat zur topischen verwendung
DE69429806T2 (de)	2002-09-12	Pharmazeutische zusammensetzungen zur prävention und behandlung von krebserkrankungen und verfahren für ihre herstellung
DE69127087T2 (de)	1998-01-15	Wachstumsfaktor und glutamin enthaltendes produkt und verwendung des wachstumsfaktors zur behandlung der darmschleimhaut
DE69529213T2 (de)	2003-11-13	Verwendung von magnesium enthaltenden verbindungen zur behandlung oder prophylaxe von krebs- und autoimmunkrankheiten
DE3650620T2 (de)	1997-09-11	Behandlungsverfahren kataboler dysfunktion
CH646056A5 (de)	1984-11-15	Lipide senkendes mittel.
DE68912850T2 (de)	1994-06-16	Aktivitätspotenziator gegen Krebs.
DE2921312A1 (de)	1979-12-06	Pharmazeutisches mittel und dessen verwendung bei einer vollstaendig parenteralen ernaehrung
DE3119460A1 (de)	1982-03-04	Pharmazeutische zusammensetzung aus l-karnitin und/oder l-acylkarnitin und verwendung der zusammensetzung gegen diabetes mellitus bei jugendlichen
DE69021415T2 (de)	1996-04-25	Mittel zur Behandlung von seniler Demenz, Gedächtnisstörungen und ähnlichen Zuständen.
DE60015560T2 (de)	2005-12-15	Verwendung von aminosäure zur herstellung von arzneimitteln zur behandlung von insulinresistenz
DE69023989T2 (de)	1996-05-15	Verwendung von Vitamin B6 zur Verminderung von hohem Serotoninspiegel.
DE3427797A1 (de)	1986-02-06	Zytoprotektive wirkung von prostacyclin-derivaten an leber, bauchspeicheldruese und niere
DE2335215B2 (de)	1979-04-05	Verwendung einer Mischung bei der Bekämpfung von zur Urämie führenden Nierenerkrankungen
DE69430416T2 (de)	2002-12-05	Zusammensetzungen aus Aminosäure zur Behandlung von Infektionen
DE60207442T2 (de)	2006-07-27	VERWENDUNG EINER KOMBINATIONSZUSAMMENSETZUNG BESTEHEND AUS PROPIONYL L-CARNITIN UND WEITEREn WIRKSTOFFEn ZUR BEHANDLUNG DER EREKTILEN DYSFUNKTION

CH642541A5 - Essentielle aminosaeuren enthaltende loesung zur verabreichung an krebspatienten. - Google Patents

Info

Links

Classifications

Landscapes

Applications Claiming Priority (1)

Publications (1)

Family

ID=14492527

Family Applications (1)

Country Status (10)

Cited By (1)

Families Citing this family (45)

Family Cites Families (5)

Cited By (1)

Also Published As

Similar Documents

Legal Events